https://www.avient.com/sites/default/files/resources/Terms%2520and%2520Conditions%2520of%2520Sale%2520for%2520Hungary.pdf
Eladó semmiképpen sem felel Vevő felé bármely véletlenszerű, következményi vagy különös károkért, ideértve, de nem kizárólag az elmaradt hasznot.
A vis major megszűnése esetén a teljesítés visszaáll, de a késedelem, kivéve a közös megállapodást, nem haladhatja túl a vonatkozó vételi megrendelés(ek) feltételeit, továbbá nem kötelezheti Eladót, hogy pótoljon elmaradt szállítmányokat vagy a Vevőt, hogy vásároljon elmaradt árumennyiséget.
Vevő ezen információkat továbbadja, hogy figyelmeztesse a lehetséges veszélyekre azokat a személyeket, akik a Vevő szerint előreláthatóan ki vannak téve ezen veszélyeknek, beleértve, de nem kizárólag a Vevő alkalmazottait, megbízottait, alvállalkozóit és vevőit.
https://www.avient.com/sites/default/files/2021-01/clariant-plastics-coatings-usa-llc-de-amendment-change-of-name-jan-15-2021.pdf
https://www.avient.com/sites/default/files/2023-01/ECCOH XL Cross-Linkable Solutions for Photovoltaic Cable _8148_ Product Bulletin.pdf
They pass EN 50618 and IEC 60332-1 standards on the assembled cable (if the cable jacketing and insulation are both produced with ECCOH XL 8148 solutions).
https://www.avient.com/sites/default/files/2023-06/Cesa_ Stat Antistatic Additives for Automotive - Application Bulletin.pdf
Cesa Stat Antistatic Additives for automotive can support customers with electrostatic decay time testing according to Standard DIN EN 61340-2-1 to speed up the development.
https://www.avient.com/sites/default/files/2021-09/avient2020sustainabilityreport-9-2-21.pdf
Lomas de Zamora, Argentina 48.
Guatemala City, Guatemala 69.
While conventional air emissions are a critical and a highly-influential topic in some industrial sectors, as a specialty formulator of purchased materials, Avient’s conventional air emission levels are de minimis and not material.
https://www.avient.com/sites/default/files/2021-03/avient-march-ir-fermium_0.pdf
Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 24 Capex / Revenue 2021E (%) AVIENT IS ASSET LIGHT Avient Specialty Formulators Other Chemical/Specialty Companies 2 3 2 2 3 3 3 4 3 3 4 4 4 5 5 5 5 7 7 8 23 A vi en t A vi en t (E xc l.
Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 84% Median: 77% HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $510M and excludes one-time synergy capture CAPEX ($20M) Source: Peer data per Bloomberg market data as of March 12, 2021 85 89 86 86 82 80 76 89 85 83 82 81 78 77 77 76 75 73 70 69 49 19 A vi en t K W R P P G R P M A V Y F U L G C P F M C IF F H X L U N V R E C L A S H B N R F O E E M N C E G R A H U N K R A S C L A L B Source: Peer data per Bloomberg market data as of March 12, 2021 Total Enterprise Value / 2021E EBITDA Our current valuation implies an EBITDA multiple that is below specialty formulator peers and some of our more highly valued chemical peers.
With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 26 Avient reflects 2021 estimated EBITDA of $510M OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 11.3 18.6 14.3 13.6 13.3 12.2 10.7 28.8 26.3 23.3 14.6 12.4 11.7 11.6 11.2 11.0 10.6 10.3 9.6 9.1 8.5 7.2 A vi en t K W R A V Y R P M P P G G C P F U L H X L A L B E C L IF F F M C A S H F O E B N R C E G R A E M N S C L U N V R K R A H U N Median: 11.2xMedian: 13.5x SUMMARY: WHY INVEST IN AVIENT?
https://www.avient.com/sites/default/files/2021-05/avnt-first-quarter-2021-earnings-presentation.pdf
Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 18 Capex / Revenue 2021E (%) AVIENT IS ASSET LIGHT Avient Specialty Formulators Other Chemical/Specialty Companies 2 3 2 2 2 3 3 4 3 3 3 4 4 5 5 5 6 7 7 8 24 A vi en t A vi en t (E xc l.
Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 84% Median: 77% HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $560M and excludes one-time synergy capture CAPEX ($20M) Source: Peer data per Bloomberg market data as of April 27, 2021 87 89 87 86 82 81 76 88 87 84 82 81 78 77 77 77 76 73 70 69 50 19 A vi en t K W R P P G R P M A V Y F U L G C P F M C IF F H X L U N V R E C L A S H C E B N R F O E E M N G R A H U N K R A S C L A L B Source: Peer data per Bloomberg market data as of April 27, 2021 Total Enterprise Value / 2021E EBITDA Our current valuation with updated guidance implies an EBITDA multiple that is below specialty formulator peers and the majority of our chemical peers.
With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 20 Avient reflects 2021 estimated EBITDA of $560M OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 10.2 17.7 16.0 14.9 14.6 11.6 11.1 26.7 24.0 22.8 14.3 12.7 11.5 11.2 11.1 11.0 10.3 10.1 9.5 9.4 8.3 7.0 A vi en t K W R A V Y R P M P P G G C P F U L A L B H X L E C L IF F F M C B N R A S H G R A F O E S C L E M N U N V R C E K R A H U N Median: 11.1xMedian: 14.8x SUMMARY: WHY INVEST IN AVIENT?
https://www.avient.com/sites/default/files/2022-03/AVNT Mar 2022 Presentation.pdf
OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 5.4 8.5 10.1 10.0 15.7 15.0 14.2 12.7 10.2 25.0 19.7 17.7 13.2 12.3 10.0 9.9 8.9 8.5 8.3 6.6 A vi en t (2 01 1) A vi en t (2 01 6) A vi en t (2 02 1) A vi en t (T o da y) R P M K W R P P G A V Y F U L A L B E C L H X L A S H F M C B N R E M N U N V R C E S C L H U N Historic Multiple SUMMARY: WHY INVEST IN AVIENT?
https://www.avient.com/sites/default/files/2021-04/avient-q4-earnings-and-2021-outlook-website.pdf
Whether an additional line at an existing manufacturing plant, or a new facility in a growing region, we ramp-up quickly and cost-efficiently. 22 Capex / Revenue 2021E (%) AVIENT IS ASSET LIGHT Avient Specialty Formulators Other Chemical/Specialty Companies 2 3 2 2 2 3 3 6 2 3 4 4 5 5 5 6 6 6 7 9 25 A vi en t A vi en t (E xc l.
Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 83% Median: 76% HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $510M and excludes one-time synergy capture CAPEX ($20M) Source: Peer data per Bloomberg market data as of February 5, 2021 85 87 86 86 81 81 59 92 88 81 79 79 79 76 76 75 73 67 67 64 60 7 A vi en t P P G K W R R P M F U L A V Y G C P IF F F M C U N V R H X L E M N B N R E C L C E A S H F O E G R A H U N K R A S C L A L B Source: Peer data per Bloomberg market data as of February 5, 2021 Total Enterprise Value / 2021E EBITDA Our current valuation implies an EBITDA multiple that is significantly below specialty formulator peers and our historic valuations, when the company had considerable exposure to more cyclical and challenging end markets.
With the Clariant Masterbatch acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets, with increased geographic diversification and a more specialized portfolio that can significantly expand EBITDA margins. 24 Avient reflects 2021 estimated EBITDA of $510M OUR VALUATION VERSUS PEERS Avient Specialty Formulators Other Chemical/Specialty Companies 9.5 21.1 13.2 13.2 12.0 12.0 9.7 25.2 23.1 14.7 13.5 12.9 11.0 11.0 11.0 10.2 9.6 9.3 9.3 9.1 8.6 8.3 A vi en t K W R A V Y R P M G C P P P G F U L A L B E C L H X L IF F F M C G R A B N R F O E A S H C E S C L U N V R E M N H U N K R A Median: 11.0xMedian: 12.6x SUMMARY: WHY INVEST IN AVIENT?
https://www.avient.com/sites/default/files/2025-03/ColorMatrix LQ_Extrusion Sheet _ Strap_Case study snapshot.pdf
PVC EDGE BANDING MANUFACTURER E X T R U S I O N S H E E T & S T R A P • Meet the diverse coefficient of friction (CoF) requirements across various film structures and compositions for a wide range of applications • Improve the speed of slip blooming and ensure consistent slip performance post-film production • Preserve excellent optical and mechanical properties • Compliance with food regulations for end packaging in food sealant applications • Achieved the optimal flowability of liquid white and liquid orange, ensuring consistent color through suitable mixing with other colorants • Ensured lot-to-lot consistency with DE value of less than 0.5 • Supported customers in achieving stable and high-quality coloration during their PVC processing ColorMatrix Liquid Color Concentrates KEY REQUIREMENT WHY AVIENT AVIENT SOLUTION FUNCTIONALITY + COMPLIANCE Avient Corporation 1 • Meet the diverse coefficient of friction (CoF) requirements across various film structures and compositions for a wide range of applications • Improve the speed of slip blooming and ensure consistent slip performance post-film production • Preserve excellent optical and mechanical properties • Compliance with food regulations for end packaging in food sealant applications KEY REQUIREMENT • Standard colorant for internal color matching in PVC sheet applications • Manufactured with phthalate-free plasticizer • Good thermal stability and compatibility with PVC resin for a wide rang of color index choices • Compliance with heavy metal-free and RoHS regulations LIQUID COLOR CONCENTRATES AND DOSING | AVIENTLEARN MORE KEY REQUIREMENTS Copyright © 2025, Avient Corporation.